logo image
search icon
Intravenous Immunoglobulin Market

Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report by Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies), Region And Segment Forecasts, 2023-2031

Report ID : 1874 | Published : 2023-06-22 | Pages: 180 | Format: PDF/EXCEL

The Global Intravenous Immunoglobulin Market Size is valued at 12.03 billion in 2022 and is predicted to reach 21.22 billion by the year 2031 at a 6.6% CAGR during the forecast period for 2023-2031.

Immunoglobulins are glycoprotein molecules produced by plasma or white blood cells. Immunoglobulins serve as a crucial line of defense for the immune system, recognizing and attaching to certain antigens such as bacteria and viruses and aiding in their elimination. Intravenous immunoglobulins are immunoglobulins that are delivered intravenously. Because most patients getting immunoglobulins are in hospitals or clinical settings, intravenous immunoglobulins are the most commonly used mode of administration. This, along with the immunoglobulins' demonstrated efficacy as an effective therapy choice for various immunological illnesses and a lack of training for homecare settings, is driving the Intravenous Immunoglobulin market expansion.

Intravenous Immunoglobulin Market

However, tight government rules regarding the use of intravenous immunoglobulin products and the significant risk of side effects associated with them are projected to hamper market expansion. On the contrary, the widespread use of intravenous immunoglobulin for treating various disorders is projected to open up profitable opportunities shortly. 

Recent Developments:

  • In March 2022, Sanofi and Seagen Inc. agreed to work exclusively to discover, develop, and commercialize antibody-drug conjugates (ADCs) targeting up to three cancer targets. Sanofi's unique monoclonal antibody (mAb) technology and Seagen's patented ADC technology will be used in the cooperation. 

Competitive Landscape:

Some of the Intravenous Immunoglobulin market players are:

  • Biotest AG
  • Baxter International Inc.
  • Octapharma AG
  • LFB Biotechnologies
  • Grifols SA
  • CSL Behring
  • China Biologics Products Inc.
  • Kedrion Biopharma
  • BDI Pharma Inc  

Market Segmentation:

The Intravenous Immunoglobulin market is segmented based on application and distribution channel. The application segment includes hypogammaglobulinemia, immunodeficiency diseases, congenital AIDS, chronic lymphocytic leukemia, CIPDmyasthenia gravis, multifocal motor neuropathy, tip, Kawasaki disease, guillain-barre syndrome, and others. The market is segmented by distribution channel into hospital pharmacies, speciality pharmacies, and others.

Based On Application, The Immunodeficiency Diseases Segment Is A Major Contributor To The Intravenous Immunoglobulin Market

The immunodeficiency diseases category will hold a major share of the global Intravenous Immunoglobulin market in 2022. This is attributed to the rising prevalence of primary and acquired immunodeficiency illnesses (PID & AID). PID and AID require IV antibiotics to clear the diseases. IVIG replacement therapy is the most effective treatment option for immunodeficiency illnesses. As a result, the company is likely to grow steadily in the following years.

The Hospital Pharmacies Segment Noticed Growth At A Rapid Rate

The hospital pharmacies segment is projected to grow rapidly in the global Intravenous Immunoglobulin market because of the extensive hospital network and the handy choice of products available through hospital pharmacies. Furthermore, the rising prevalence of primary immunological deficiencies, hepatitis C, and other disorders has increased the frequency of hospitalizations worldwide, increasing customer demand for hospital pharmacies. Furthermore, hospitals provide prompt reimbursement, treatment, and proper care to many patients, expanding the number of patients using hospital pharmacies.

The North America Intravenous Immunoglobulin Market Holds A Significant Revenue Share In The Region

The North America Intravenous Immunoglobulin market is expected to register the highest market share in revenue shortly. The major factors driving market expansion are the rising level of awareness about goods used to treat immunodeficiency illnesses, expanding clinician interest in these medicines, and rising healthcare expenditure.

Furthermore, the increasing use of IVIG therapies for illness treatment, established healthcare and research infrastructure, and the rapidly growing number of product approvals from the US FDA are expected to contribute to the region's revenue growth. In addition, Asia Pacific is projected to raise at a rapid rate in the global Intravenous Immunoglobulin market due to Emerging economies, rising healthcare spending, and a fast-expanding immunoglobulin market are all factors to consider.

Intravenous Immunoglobulin Market Report Scope:

Report Attribute

Specifications

Market size value in 2022

USD 12.03 Bn

Revenue forecast in 2031

USD 21.22 Bn

Growth rate CAGR

CAGR of 6.6% from 2023 to 2031

Quantitative units

Representation of revenue in US$ Million, and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report coverage

The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends

Segments covered

Type And Application

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia

Competitive Landscape

Biotest AG, Baxter International Inc., Octapharma AG, LFB Biotechnologies, Grifols SA, CSL Behring, China Biologics Products Inc., Kedrion Biopharma, BDI Pharma Inc.

Customization scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and available payment methods

Explore pricing alternatives that are customized to your particular study requirements.

 

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Intravenous Immunoglobulin Market Snapshot

Chapter 4. Global Intravenous Immunoglobulin Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry

Chapter 5. Market Segmentation 1: By Distribution Channel Estimates & Trend Analysis
5.1. By Distribution Channel & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Distribution Channel:

5.2.1. Hypogammaglobulinemia
5.2.2. CIPD
5.2.3. Immunodeficiency diseases
5.2.4. Congenital AIDS
5.2.5. Chronic Lymphocytic Leukemia
5.2.6. Myasthenia Gravis
5.2.7. Multifocal motor neuropathy
5.2.8. ITP
5.2.9. Kawasaki disease
5.2.10. Guillain-Barre syndrome
5.2.11. Others

Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following by Application:

6.2.1. Intravenous
6.2.2. Subcutaneous

Chapter 7. Intravenous Immunoglobulin Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Intravenous Immunoglobulin Market revenue (US$ Million) estimates and forecasts by Distribution Channel, 2023-2031
7.1.2. North America Intravenous Immunoglobulin Market Revenue (US$ Million) Estimates and Forecasts By Application, 2023-2031
7.1.3. North America Intravenous Immunoglobulin Market revenue (US$ Million) estimates and forecasts by country, 2023-2031

7.1.3.1. U.S.
7.1.3.2. Canada

7.2. Europe

7.2.1. Europe Intravenous Immunoglobulin Market Revenue (US$ Million) by By Distribution Channel, 2023-2031
7.2.2. Europe Intravenous Immunoglobulin Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
7.2.3. Europe Intravenous Immunoglobulin Market revenue (US$ Million) by country, 2023-2031

7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. UK
7.2.3.7. Rest of Europe

7.3. Asia Pacific

7.3.1. Asia Pacific Intravenous Immunoglobulin Market revenue (US$ Million) by By Distribution Channel, 2023-2031
7.3.2. Asia Pacific Intravenous Immunoglobulin Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
7.3.3. Asia Pacific Intravenous Immunoglobulin Market revenue (US$ Million) by country, 2023-2031

7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific


7.4. Latin America

7.4.1. Latin America Intravenous Immunoglobulin Market revenue (US$ Million) by By Distribution Channel, 2023-2031
7.4.2. Latin America Intravenous Immunoglobulin Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
7.4.3. Latin America Intravenous Immunoglobulin Market revenue (US$ Million) by country, (US$ Million) 2023-2031

7.4.3.1. Brazil
7.4.3.2. Rest of Latin America

7.5. Middle East & Africa

7.5.1. Middle East & Africa Intravenous Immunoglobulin Market revenue (US$ Million) by By Distribution Channel, (US$ Million)
7.5.2. Middle East & Africa Intravenous Immunoglobulin Market revenue (US$ Million) estimates and forecasts By Application, 2023-2031
7.5.3. Middle East & Africa Intravenous Immunoglobulin Market revenue (US$ Million) by country, (US$ Million) 2023-2031

7.5.3.1. South Africa
7.5.3.2. GCC Countries
7.5.3.3. Rest of MEA

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles


8.2.1. Biotest AG
8.2.2. Baxter International Inc.
8.2.3. Octapharma AG
8.2.4. LFB Biotechnologies
8.2.5. Grifols SA
8.2.6. CSL Behring
8.2.7. China Biologics Products Inc.
8.2.8. Kedrion Biopharma
8.2.9. BDI Pharma Inc..

Segmentation of Intravenous Immunoglobulin Market-

Intravenous Immunoglobulin Market By Application-

  • Hypogammaglobulinemia
  • CIPD
  • Immunodeficiency Diseases
  • Congenital AIDS
  • Chronic Lymphocytic Leukemia
  • Myasthenia Gravis
  • Multifocal Motor Neuropathy
  • ITP
  • Kawasaki Disease
  • Guillain-barre Syndrome
  • Others

Intravenous Immunoglobulin Market

Intravenous Immunoglobulin Market By Distribution Channel-

  • Hospital Pharmacy
  • Specialty Pharmacy
  • Others

Intravenous Immunoglobulin Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa

Rest of Middle East and Africa

 InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Intravenous Immunoglobulin Market?

Intravenous Immunoglobulin Market expected to grow at a 6.6% CAGR during the forecast period for 2023-2031

Biotest AG, Baxter International Inc., Octapharma AG, LFB Biotechnologies, Grifols SA, CSL Behring, China Biologics Products Inc., Kedrion Biopharma,

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach